nefXtend study: Extension for TARPEYO® (budesonide) delayed release capsules

If you’re taking TARPEYO® (budesonide) delayed release capsules and coming to the end of your 9-month treatment course, a new clinical study may be a potential option for you. The NefXtend Study is being conducted by Apex Clinical Research of Georgia to evaluate a 15-month treatment extension of TARPEYO®.